Global Market Insights

@IQVIA_GMI

Global Market Insights supports our clients in measuring, managing & segmenting markets to find opportunities and maximize investment across the drug lifecycle

Vrijeme pridruživanja: travanj 2010.

Tweetovi

Blokirali ste korisnika/cu @IQVIA_GMI

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IQVIA_GMI

  1. In the prescription market, injectables have the strongest market value growth, with a CAGR of 10%. Learn how the changing make up of the prescription market affects drug formulations, delivery and packaging with Yasemin Karanis’ latest article.

    Poništi
  2. 4. velj

    With the conduction of basket trials and recurrent highlights in reputable cancer conferences, precision medicine is gaining its much-deserved spotlight. Learn moreabout therapy developments on

    Poništi
  3. 4. velj

    Wondering what a strategy for looks like? Hear from Aurelio Arias at his presentation on ‘Digital Value Added Medicines’ at 2020

    Poništi
  4. 4. velj

    Today is . A pooled analysis of clinical trials for a TRK inhibitor found that the overall response rate in patients was 72%, including 16% with complete responses. Check for other therapies in active development

    Poništi
  5. 4. velj

    Today is . Get a vision on the concept, challenges and future direction of tissue-agnostic therapies with the blog.

    Poništi
  6. 3. velj

    Want to know more about future opportunities? Join Aurelio Arias at his presentation on the 'Global Outlook for Biologics and Biosimilars' at 2020

    Poništi
  7. 3. velj

    Looking ahead, two key trends in are expected to be the rise of specialty and the increasing importance of biologics, as 45% of the pipeline today are biologics. Learn more drug delivery trends with Yasemin Karanis’ article

    Poništi
  8. 3. velj

    Aurelio Arias from the IQVIA Thought Leadership team will be presenting on the role of devices in at 2020

    Poništi
  9. 31. sij

    Going to be at 2020? Join Aurelio Arias as he presents on the 'Global Outlook for Biologics and Biosimilars' at session 3 of the conference

    Poništi
  10. 31. sij

    The analysis of Big Data represents one of the biggest challenges in Pharmacovigilance", as reported by the team from

    Poništi
  11. 31. sij

    reported that the 3 pillars of the strategy until 2025 are: to drive operational excellence in regulatory processes, to respond to globalization and to increase access to medicines

    Poništi
  12. 30. sij

    come meet us at our stand to discuss the future of regulatory affairs, and how our experts can support you.

    Poništi
  13. 28. sij

    Read the article titled ‘Pharma Outlook: 10 trends to look out for in 2020’ for 10 leading industry players opinions on key trends across the entire pharma supply chain that they believe the industry needs to keep up with in 2020.

    Poništi
  14. 28. sij

    Compared to small molecules, are harder to manufacture, keep and administer. Learn how packaging, and play a key role in biologics drug delivery with Yasemin Karanis', IQVIA Thought Leadership, latest article.

    Poništi
  15. 27. sij

    In most countries, market sales growth is expected to exceed volume growth. What factors are driving this dynamic? Is there anything on the horizon that will change this trend? Read IQVIA ’s latest blog to learn more

    Poništi
  16. 24. sij

    In next 5 years exclusivity rights for drugs will expire, the majority for new dosage forms in Japan & Korea. Upon expiry, generic companies can develop different formulations in those areas.

    Poništi
  17. 24. sij

    While the commercial future of remains uncertain, truly global biosimilar prospects will need viable access to the US market with the highest opportunities. Read the latest blog from Aurelio Arias to learn more

    Poništi
  18. 23. sij

    Going to be attending ? Meet the team to discuss the future of affairs with our industry experts

    Poništi
  19. 23. sij

    Global market sales are forecast to grow at a slow rate to 2028. What are the key factors influencing the forecast? Read more in IQVIA ’s latest blog

    Poništi
  20. 23. sij

    We are proud to announce IQVIA was named to 's “World’s Most Admired Companies” list! As the definitive report card on corporate reputation, this is a great honor.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·